Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

The Role of hs Troponin I and NT-proBNP in Predicting Atrial Fibrillation in Patients With Permanent Pacemakers

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this clinical trial is to answer the research question whether hs Troponin I and NT-proBNP have a role in detecting atrial fibrillation in patients with pacemakers. Objectives of the study: 1. To survey some risk factors for atrial fibrillation in patients with permanent pacemakers. 2. To determine the role of hs Troponin I and NT-proBNP in predicting new-onset atrial fibrillation within follow-up time. 3. To build a model to predict the prognosis of atrial fibrillation based on the detected subclinical markers related to atrial fibrillation and classic cardiovascular risk factors.

Who May Be Eligible (Plain English)

Who May Qualify: - Patient is an adult (≥ 18 years old or older) - There is indication for permanent pacemaker placement and patient agreement to permanent pacemaker placement - Patient agrees to participate in the study Who Should NOT Join This Trial: - Patients had a diagnosis of atrial fibrillation in their past history or atrial fibrillation is discovered at the time of participating in the study - Severe patients, at risk of death - Pregnant - The patient is indicated for surgery - Patients with eGFR ≤ 30 mL/min/1.73m2 - The patient has a serious infection Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patient is an adult (≥ 18 years old or older) * There is indication for permanent pacemaker placement and patient agreement to permanent pacemaker placement * Patient agrees to participate in the study Exclusion Criteria: * Patients had a diagnosis of atrial fibrillation in their past history or atrial fibrillation is discovered at the time of participating in the study * Severe patients, at risk of death * Pregnant * The patient is indicated for surgery * Patients with eGFR ≤ 30 mL/min/1.73m2 * The patient has a serious infection

Locations (1)

Cho Ray Hospital
Ho Chi Minh City, None Selected, Vietnam